A “federation of 27 companies”.

François Billig, CEO of the Acrotec Group, recaps the values, success and goals of the group for 2023 in his interview with JSH.

To close 2022, here are some key figures that represent the group of companies. Acrotec is more than :

  • 22 years of history
  • 2’300 employees
  • 1’500 customers
  • 2’500 machines
  • 30 production sites
  • 50 export countries

It is today 27 companies gathered in three divisions:

  • Watchmaking-Jewelry: First independent supplier of components for the Swiss watch industry. Some of the companies have been active for more than 100 years and serve all the actors of this market with whom they have built relationships since their creation. All the products offered by the companies of the group meet the best quality standards established by its customers and respect the Swiss Made criteria. The group is also positioned in the field of jewelry with the manufacture of jewelry.
  • Medtech: The group has acquired and developed the skills necessary for the manufacture of precision components and sub-assemblies for medical devices. The companies of the group specialized in the Medtec field have become trusted partners for the production of parts and instruments.
  • Precision High Tech: Thanks to its expertise and the quality processes of its partners, the companies of the group are able to respond with consistency and continuity to the demands of the main suppliers in the precision high-tech sector. The experience makes the group a long-standing partner in the production of precision components.

François Billig’s entrepreneurial spirit sets no limits. The important thing for the group is to be in phase with the expectations of the market and the needs of the customer. The secret of the group’s growth is to remain focused on what Acrotec and its companies know how to do in the field of high precision, whether it is in the watchmaking, medical, automotive, electronic or aerospace sectors.

The group’s philosophy is to respect the DNA, identity and autonomy of each of its member companies. They all have one thing in common: the desire to take a new step, to take advantage of the synergies between the companies in the group, the desire to innovate, to prepare an efficient succession or to be part of a “one-spot-shop” that has proven itself.

The group knows how to constantly adapt to market developments with an exceptional opportunity to offer innovative solutions combined with the skills and historical know-how of the companies.

By the end of 2023, the group wants to strengthen the medtech sector in North America to take a further step in balancing the different business areas.

Find the complete interview of François Billig, CEO of the Acrotec Group on the link of the article written by Joël A. Grandjean published in the Journal Suisse de l’Horlogerie.